National Research Stock Price, News & Analysis (NASDAQ:NRC) $41.50 0.00 (0.00%) (As of 12/5/2023 ET) Add Compare Share Share Today's Range$41.41▼$41.6050-Day Range$40.51▼$46.3952-Week Range$36.61▼$47.60Volume122,394 shsAverage Volume37,763 shsMarket Capitalization$1.02 billionP/E Ratio35.78Dividend Yield1.16%Price TargetN/A Stock AnalysisStock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media National Research MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy0.88% of Float Sold ShortDividend StrengthWeakBased on Four FactorsSustainabilityN/ANews Sentiment0.16Based on 2 Articles This WeekInsider TradingSelling Shares$117,651 Sold Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.67 out of 5 starsBusiness Services Sector243rd out of 285 stocksCommercial Physical Research Industry10th out of 10 stocks N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for National Research. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.88% of the float of National Research has been sold short.Short Interest Ratio / Days to CoverNational Research has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in National Research has recently increased by 31.91%, indicating that investor sentiment is decreasing significantly. Previous Next 1.7 Dividend Strength Dividend YieldNational Research pays a meaningful dividend of 1.16%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthNational Research does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of National Research is 41.38%. This payout ratio is at a healthy, sustainable level, below 75%. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for NRC. Previous Next 1.2 News and Social Media Coverage News SentimentNational Research has a news sentiment score of 0.16. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.37 average news sentiment score of Business Services companies.News Coverage This WeekMarketBeat has tracked 2 news articles for National Research this week, compared to 2 articles on an average week. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, National Research insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $117,651.00 in company stock.Percentage Held by InsidersOnly 2.40% of the stock of National Research is held by insiders.Percentage Held by Institutions47.26% of the stock of National Research is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of National Research is 35.78, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 117.51.Price to Earnings Ratio vs. SectorThe P/E ratio of National Research is 35.78, which means that it is trading at a less expensive P/E ratio than the Business Services sector average P/E ratio of about 35.93.Price to Book Value per Share RatioNational Research has a P/B Ratio of 14.21. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About National Research Stock (NASDAQ:NRC)National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, workforce engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.Read More NRC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NRC Stock News HeadlinesDecember 4, 2023 | finance.yahoo.comB.C. cleantech businesses receive $2M from Innovate BC and NRC IRAP through BC Fast PilotNovember 30, 2023 | msn.comGood guys with guns save lives. Don’t believe the hype.December 6, 2023 | DTI Trader (Ad)New CBOE “special perk” helps traders target income every weekendYou might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange. November 27, 2023 | au.news.yahoo.comRussia prepares new lists of Ukrainian children for deportation, says NRCNovember 26, 2023 | americanbankingnews.comNational Research (NASDAQ:NRC) Sees Unusually-High Trading VolumeNovember 24, 2023 | finance.yahoo.comNational Research (NASDAQ:NRC) Has Affirmed Its Dividend Of $0.12November 13, 2023 | news.yahoo.comNo signs of Russian retreat from occupied left bank in Kherson Oblast, reports NRCNovember 9, 2023 | finance.yahoo.comNational Research Corporation (NASDAQ:NRC) Q3 2023 Earnings Call TranscriptDecember 6, 2023 | DTI Trader (Ad)New CBOE “special perk” helps traders target income every weekendYou might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange. November 7, 2023 | finance.yahoo.comNational Research Corporation Announces Third Quarter 2023 ResultsNovember 6, 2023 | finance.yahoo.comShould Weakness in National Research Corporation's (NASDAQ:NRC) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?November 5, 2023 | msn.comSupermassive black holes are very messy eatersNovember 4, 2023 | msn.comRussians threaten to sack holders of Ukrainian citizenship from their jobs in occupied territoriesOctober 24, 2023 | finance.yahoo.comNational Research Corporation to Broadcast its 2023 Third Quarter Conference Call Live on the InternetOctober 23, 2023 | msn.comIncome contingent loan won't overburden PTPTN borrowers - AnwarOctober 13, 2023 | msn.comNat'l Rehabilitation Commission, Civil Society Organizations Council Agree to Work TogetherOctober 10, 2023 | msn.comThe end of the long dash: CBC stops broadcasting official time signalOctober 10, 2023 | msn.comAnti-Russian sentiment growing sharply in occupied Crimea - Resistance Center reveals reasonOctober 10, 2023 | ca.news.yahoo.comThe end of the long dash: CBC stops broadcasting official 1 p.m. time signalOctober 9, 2023 | msn.comRehabilitation clinic for people with serious injuries and illnesses under way near LoughboroughOctober 5, 2023 | finance.yahoo.comKatipult Receives Additional Support to Propel Digital Private Capital NetworkOctober 4, 2023 | msn.com'Phenomenal' national rehabilitation centre in Nottinghamshire set to become first of its kindOctober 4, 2023 | msn.comPioneering facility to ‘transform how we provide clinical rehabilitation’ in UKOctober 4, 2023 | ca.news.yahoo.comU of A engineering student develops a device to help predict algae bloomsOctober 4, 2023 | proactiveinvestors.comHillcrest Energy secures government funding for electric vehicle inverter development programSeptember 26, 2023 | finance.yahoo.comLurie Children’s expands partnership with NRC Health to gain valuable consumer insightsSeptember 21, 2023 | news.yahoo.comGovernment approves £105m Stanford Hall NHS rehabilitation centreSee More Headlines Receive NRC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for National Research and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 9/22 Dividend9/15/2023Dividend Payable9/22/2023Last Earnings11/07/2023Today12/05/2023Ex-Dividend for 1/12 Dividend12/28/2023Fiscal Year End12/31/2023Dividend Payable1/12/2024Next Earnings (Estimated)2/13/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Commercial physical research Sub-IndustryN/A SectorBusiness Services Current SymbolNASDAQ:NRC CUSIPN/A CIK70487 Webwww.nrchealth.com Phone(402) 475-2525Fax402-475-9061Employees491Year Founded1981Profitability EPS (Most Recent Fiscal Year)$1.16 Trailing P/E Ratio35.78 Forward P/E RatioN/A P/E GrowthN/ANet Income$31.80 million Net Margins19.33% Pretax Margin25.53% Return on Equity40.74% Return on Assets22.18% Debt Debt-to-Equity Ratio0.24 Current Ratio0.61 Quick Ratio0.61 Sales & Book Value Annual Sales$151.57 million Price / Sales6.72 Cash Flow$1.51 per share Price / Cash Flow27.57 Book Value$2.92 per share Price / Book14.21Miscellaneous Outstanding Shares24,560,000Free Float23,969,000Market Cap$1.02 billion OptionableNot Optionable Beta0.43 Social Links 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Michael D. Hays (Age 68)Founder, CEO, President & Director Comp: $131.65kMr. Kevin R. Karas CPA (Age 65)Senior VP of Finance, CFO, Treasurer & Secretary Comp: $292.81kMs. Jona S. Raasch (Age 64)Chief Operating Officer Comp: $308.01kMs. Helen L. Hrdy (Age 58)Chief Growth Officer Comp: $291.31kMr. Jon BoumsteinChief Delivery OfficerDr. Gregory Makoul M.S.Ph.D., Chief Transformation OfficerLinda StacyVice President of FinanceMegan CharkoSenior Manager of Content MarketingMore ExecutivesKey CompetitorsSomaLogicNASDAQ:SLGCMarketWiseNASDAQ:MKTWAdeiaNASDAQ:ADEAMontrose Environmental GroupNYSE:MEGAdvantage SolutionsNASDAQ:ADVView All CompetitorsInsiders & InstitutionsAmerican Century Companies Inc.Bought 3,332 shares on 11/30/2023Ownership: 0.065%Deutsche Bank AGBought 1,025 shares on 11/24/2023Ownership: 0.038%Amandla Mk TrustSold 627 sharesTotal: $26,384.16 ($42.08/share)Comerica BankBought 156,392 shares on 11/21/2023Ownership: 0.637%Amandla Mk TrustSold 57 sharesTotal: $2,399.70 ($42.10/share)View All Insider TransactionsView All Institutional Transactions NRC Stock Analysis - Frequently Asked Questions How have NRC shares performed in 2023? National Research's stock was trading at $37.30 on January 1st, 2023. Since then, NRC stock has increased by 11.3% and is now trading at $41.50. View the best growth stocks for 2023 here. Are investors shorting National Research? National Research saw a increase in short interest in November. As of November 15th, there was short interest totaling 126,900 shares, an increase of 31.9% from the October 31st total of 96,200 shares. Based on an average daily trading volume, of 39,500 shares, the short-interest ratio is currently 3.2 days. Approximately 0.9% of the shares of the stock are sold short. View National Research's Short Interest. When is National Research's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 13th 2024. View our NRC earnings forecast. How were National Research's earnings last quarter? National Research Co. (NASDAQ:NRC) released its quarterly earnings results on Tuesday, November, 7th. The company reported $0.32 EPS for the quarter. The company had revenue of $37.95 million for the quarter. National Research had a net margin of 19.33% and a trailing twelve-month return on equity of 40.74%. How often does National Research pay dividends? What is the dividend yield for National Research? National Research declared a quarterly dividend on Friday, November 17th. Shareholders of record on Friday, December 29th will be paid a dividend of $0.12 per share on Friday, January 12th. This represents a $0.48 annualized dividend and a yield of 1.16%. The ex-dividend date of this dividend is Thursday, December 28th. Read our dividend analysis for NRC. Is National Research a good dividend stock? National Research (NASDAQ:NRC) pays an annual dividend of $0.48 per share and currently has a dividend yield of 1.16%. The dividend payout ratio is 41.38%. This payout ratio is at a healthy, sustainable level, below 75%. Read our dividend analysis for NRC. What ETF holds National Research's stock ? Small Cap US Equity Select ETF holds 16,946 shares of NRC stock, representing 2.76% of its portfolio. What is Michael D. Hays' approval rating as National Research's CEO? 85 employees have rated National Research Chief Executive Officer Michael D. Hays on Glassdoor.com. Michael D. Hays has an approval rating of 87% among the company's employees. What other stocks do shareholders of National Research own? Based on aggregate information from My MarketBeat watchlists, some companies that other National Research investors own include Altria Group (MO), Enterprise Products Partners (EPD), AbbVie (ABBV), Dominion Energy (D), Gilead Sciences (GILD), Pfizer (PFE), Toronto-Dominion Bank (TD), Verizon Communications (VZ), Wells Fargo & Company (WFC) and TD Ameritrade (AMTD). Who are National Research's major shareholders? National Research's stock is owned by many different retail and institutional investors. Top institutional shareholders include Kayne Anderson Rudnick Investment Management LLC (13.00%), Morgan Stanley (3.83%), Conestoga Capital Advisors LLC (3.15%), Northern Trust Corp (1.13%), Touchstone Capital Inc. (1.09%) and iA Global Asset Management Inc. (1.02%). Insiders that own company stock include Amandla Mk Trust, Joann M Martin, Jona S Raasch and Kevin R Karas. View institutional ownership trends. How do I buy shares of National Research? Shares of NRC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. Does National Research have any subsidiaries? The following companies are subsidiares of National Research: National Research Corporation Canada, PatientWisdom Inc., and The Governance Institute.Read More This page (NASDAQ:NRC) was last updated on 12/6/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding National Research Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.